Literature DB >> 22649166

Tumor-infiltrating mast cells in colorectal cancer as a poor prognostic factor.

Xianrui Wu1, Yifeng Zou, Xiaosheng He, Ruixue Yuan, Yufeng Chen, Nan Lan, Lei Lian, Fengwei Wang, Xinjuan Fan, Yang Zeng, Jia Ke, Xiaojian Wu, Ping Lan.   

Abstract

The purpose of this study is to investigate the clinical/prognostic significance of tumor-infiltrating mast cells (TIMs) in patients with colorectal cancer (CRC). TIM infiltration in 325 stage I to III CRC specimens was detected by immunohistochemistry. The optimal cutpoint of TIM density was assessed by the X-tile program. TIM infiltration in CRC was significantly higher than in normal colorectal tissues. According to the X-tile program, the cutpoint for high TIM infiltration in CRC was determined when TIM density was more than 8.0 per high-power field. Correlation analysis between TIM density and clinicopathological variables demonstrated that TIM infiltration was significantly associated with gender, nodal status, and American Joint Committee on Cancer stage. Multivariate Cox regression analysis showed that high TIM infiltration was a risk factor for both overall survival and disease-free survival. Taken together, high TIM infiltration can be an independent and useful biomarker for predicting the poor survival of patients with CRC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649166     DOI: 10.1177/1066896912448836

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  13 in total

Review 1.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

2.  Comparative Study of the Role of Interepithelial Mucosal Mast Cells in the Context of Intestinal Adenoma-Carcinoma Progression.

Authors:  Tanja Groll; Miguel Silva; Rim Sabrina Jahan Sarker; Markus Tschurtschenthaler; Theresa Schnalzger; Carolin Mogler; Daniela Denk; Sebastian Schölch; Barbara U Schraml; Jürgen Ruland; Roland Rad; Dieter Saur; Wilko Weichert; Moritz Jesinghaus; Kaspar Matiasek; Katja Steiger
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

3.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

4.  High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.

Authors:  Andrea Malfettone; Nicola Silvestris; Concetta Saponaro; Girolamo Ranieri; Antonio Russo; Stefano Caruso; Ondina Popescu; Giovanni Simone; Angelo Paradiso; Anita Mangia
Journal:  J Cell Mol Med       Date:  2013-08       Impact factor: 5.310

5.  IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer.

Authors:  Xiaowei Chen; Michael J Churchill; Karan K Nagar; Yagnesh H Tailor; Timothy Chu; Brittany S Rush; Zhengyu Jiang; Edwin B C Wang; Bernhard W Renz; Hongshan Wang; Ming Chiu Fung; Daniel L Worthley; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncotarget       Date:  2015-10-20

6.  Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.

Authors:  Christopher Johnson; Victoria Huynh; Laura Hargrove; Lindsey Kennedy; Allyson Graf-Eaton; Jennifer Owens; Jerome P Trzeciakowski; Kyle Hodges; Sharon DeMorrow; Yuyan Han; Lucas Wong; Gianfranco Alpini; Heather Francis
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

7.  Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.

Authors:  Abasi Ene-Obong; Andrew J Clear; Jennifer Watt; Jun Wang; Rewas Fatah; John C Riches; John F Marshall; Joanne Chin-Aleong; Claude Chelala; John G Gribben; Alan G Ramsay; Hemant M Kocher
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682

Review 8.  Mast cells as a potential prognostic marker in prostate cancer.

Authors:  Gianluigi Taverna; Guido Giusti; Mauro Seveso; Rodolfo Hurle; Piergiuseppe Colombo; Sanja Stifter; Fabio Grizzi
Journal:  Dis Markers       Date:  2013-11-11       Impact factor: 3.434

9.  Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer.

Authors:  Zuli Yang; Yang Bai; Lijun Huo; Hao Chen; Jintuan Huang; Jizheng Li; Xinjuan Fan; Zihuan Yang; Lei Wang; Jianping Wang
Journal:  BMC Cancer       Date:  2014-08-07       Impact factor: 4.430

10.  High infiltration of mast cells positive to tryptase predicts worse outcome following resection of colorectal liver metastases.

Authors:  Shinsuke Suzuki; Yasushi Ichikawa; Kazuya Nakagawa; Takafumi Kumamoto; Ryutaro Mori; Ryusei Matsuyama; Kazuhisa Takeda; Mitsuyoshi Ota; Kuniya Tanaka; Tomohiko Tamura; Itaru Endo
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.